Search by Drug Name or NDC
NDC 00008-1222-30 Pristiq 100 mg/1 Details
Pristiq 100 mg/1
Pristiq is a ORAL TABLET, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.. The primary component is DESVENLAFAXINE SUCCINATE.
MedlinePlus Drug Summary
Desvenlafaxine is used to treat depression. Desvenlafaxine is in a class of medications called selective serotonin and norepinephrine reuptake inhibitors (SNRIs). It works by increasing the amounts of serotonin and norepinephrine, natural substances in the brain that help maintain mental balance.
Related Packages: 00008-1222-30Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Desvenlafaxine
Product Information
| NDC | 00008-1222 |
|---|---|
| Product ID | 0008-1222_2d58c489-3d71-4a13-8ef1-dc80788feec9 |
| Associated GPIs | 58180020207540 |
| GCN Sequence Number | 063737 |
| GCN Sequence Number Description | desvenlafaxine succinate TAB ER 24H 100 MG ORAL |
| HIC3 | H7C |
| HIC3 Description | SEROTONIN-NOREPINEPHRINE REUPTAKE-INHIB (SNRIS) |
| GCN | 99452 |
| HICL Sequence Number | 035420 |
| HICL Sequence Number Description | DESVENLAFAXINE SUCCINATE |
| Brand/Generic | Brand |
| Proprietary Name | Pristiq |
| Proprietary Name Suffix | Extended-Release |
| Non-Proprietary Name | desvenlafaxine succinate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, EXTENDED RELEASE |
| Route | ORAL |
| Active Ingredient Strength | 100 |
| Active Ingredient Units | mg/1 |
| Substance Name | DESVENLAFAXINE SUCCINATE |
| Labeler Name | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. |
| Pharmaceutical Class | Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA021992 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00008-1222-30 (00008122230)
| NDC Package Code | 0008-1222-30 |
|---|---|
| Billing NDC | 00008122230 |
| Package | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0008-1222-30) |
| Marketing Start Date | 2008-05-01 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 13.9218 |
| Pricing Unit | EA |
| Effective Date | 2023-03-22 |
| NDC Description | PRISTIQ ER 100 MG TABLET |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4 |
| Classification for Rate Setting | B |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis